U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.
The Connecticut-based payer is labeling peripheral nerve stimulation, used to treat chronic pain, as medically unnecessary, with the Society of Interventional Radiology and others questioning the rationale.
Members of Congress caution that the fee could be especially consequential for rural and urban safety net hospitals, which could be pushed “to their financial brink” if they are required to absorb the charge.
Experts believe the imaging agent "has the potential to meaningfully advance early diagnosis, change the treatment paradigm and improve patient outcomes."
This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.
NXXIM will integrate all available patient data including radiology images, pathology slides and lab results into a “unified, real-time diagnostic workspace.”
In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.
For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.
